Instituto de Biomedicina de Sevilla -ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2020

  1. Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model

    Cancer Immunology, Immunotherapy, Vol. 69, Núm. 6, pp. 1001-1014

2018

  1. Therapeutic implications of NK cell regulation of allogeneic CD8 T cell-mediated immune responses stimulated through the direct pathway of antigen presentation in transplantation

    mAbs, Vol. 10, Núm. 7, pp. 1030-1044

2017

  1. Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier

    Translational Research, Vol. 181, pp. 83-95.e3

2016

  1. Immunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells

    mAbs, Vol. 8, Núm. 3, pp. 478-490